Tokyo Tape
Sign in
← Nihon Chouzai

Annual report

3341.TEDINET S100ORK1
Period2021-04-01 → 2022-03-31
Filed2022-07-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed

Amends S100ODNS. Amended by S100ORT9 (2022-07-22).

Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥299.4bn2021-04-01 → 2022-03-31Cons.Net sales
Revenue¥279.0bn2020-04-01 → 2021-03-31Cons.Net sales
Revenue¥268.5bn2019-04-01 → 2020-03-31dCons.Net sales (5-year summary)
Revenue¥245.7bn2018-04-01 → 2019-03-31dCons.Net sales (5-year summary)
Revenue¥241.3bn2017-04-01 → 2018-03-31dCons.Net sales (5-year summary)
Operating income¥6.6bn2021-04-01 → 2022-03-31Cons.Operating income
Operating income¥8.1bn2020-04-01 → 2021-03-31Cons.Operating income
Ordinary income¥6.8bn2021-04-01 → 2022-03-31Cons.Ordinary income
Ordinary income¥8.4bn2020-04-01 → 2021-03-31Cons.Ordinary income
Ordinary income¥7.4bn2019-04-01 → 2020-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥6.1bn2018-04-01 → 2019-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥10.1bn2017-04-01 → 2018-03-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥6.2bn2021-04-01 → 2022-03-31Cons.Income before income taxes
Profit before tax¥6.5bn2020-04-01 → 2021-03-31Cons.Income before income taxes
Net income (owners)¥3.7bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥3.5bn2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥6.7bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.8bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.1bn2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥3.7bn2021-04-01 → 2022-03-31Cons.Profit loss
Net income¥3.5bn2020-04-01 → 2021-03-31Cons.Profit loss
Total assets¥178.8bnat 2022-03-31Cons.Assets
Total assets¥186.3bnat 2021-03-31Cons.Assets
Total assets¥185.6bnat 2020-03-31dCons.Total assets (5-year summary)
Total assets¥178.7bnat 2019-03-31dCons.Total assets (5-year summary)
Total assets¥186.6bnat 2018-03-31dCons.Total assets (5-year summary)
Total liabilities¥125.9bnat 2022-03-31Cons.Liabilities
Total liabilities¥136.4bnat 2021-03-31Cons.Liabilities
Net assets / equity¥52.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥49.9bnat 2021-03-31Cons.Net assets
Net assets / equity¥47.1bnat 2020-03-31dCons.Net assets
Net assets / equity¥41.1bnat 2019-03-31dCons.Net assets (5-year summary)
Net assets / equity¥41.5bnat 2018-03-31dCons.Net assets (5-year summary)
Cash and deposits¥25.5bnat 2022-03-31Cons.Cash and deposits
Cash and deposits¥32.9bnat 2021-03-31Cons.Cash and deposits
Cash & equivalents¥25.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥32.9bnat 2021-03-31Cons.Cash and cash equivalents
Cash & equivalents¥32.3bnat 2020-03-31dCons.Cash and cash equivalents
Cash & equivalents¥29.7bnat 2019-03-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥28.5bnat 2018-03-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥19.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥11.2bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥13.2bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥13.6bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥23.1bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥9.3bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥7.8bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.7bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.8bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥13.8bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥17.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥2.8bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥8.0bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥10.5bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.0bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥123.562021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥118.012020-04-01 → 2021-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥223.332019-04-01 → 2020-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥121.742018-04-01 → 2019-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥190.842017-04-01 → 2018-03-31dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥1,763.34at 2022-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥1,663.01at 2021-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥1,569.77at 2020-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥1,369.52at 2019-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥1,297.5at 2018-03-31dCons.Net assets per share (5-year summary)
Equity ratio29.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio26.8%at 2021-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio25.4%at 2020-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio23.0%at 2019-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio22.3%at 2018-03-31dCons.Equity to asset ratio (5-year summary)
ROE7.2%2021-04-01 → 2022-03-31Cons.Rate of return on equity (5-year summary)
ROE7.3%2020-04-01 → 2021-03-31Cons.Rate of return on equity (5-year summary)
ROE15.2%2019-04-01 → 2020-03-31dCons.Rate of return on equity (5-year summary)
ROE9.2%2018-04-01 → 2019-03-31dCons.Rate of return on equity (5-year summary)
ROE15.7%2017-04-01 → 2018-03-31dCons.Rate of return on equity (5-year summary)
Employees5,552at 2022-03-31Cons.Number of employees
Employees5,221at 2021-03-31Cons.Number of employees
Employees4,904at 2020-03-31dCons.Number of employees
Employees4,383at 2019-03-31dCons.Number of employees
Employees4,075at 2018-03-31dCons.Number of employees
Revenue¥259.2bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥233.6bn2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥223.8bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥203.6bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥198.4bn2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income¥5.9bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income¥5.3bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income¥6.6bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥7.0bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income¥5.3bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥4.3bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥7.4bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥5.1bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax¥6.0bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income¥2.3bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥3.5bn2020-04-01 → 2021-03-31StandaloneProfit loss
Net income¥4.7bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥2.4bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income¥4.4bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥140.1bnat 2022-03-31StandaloneAssets
Total assets¥145.5bnat 2021-03-31StandaloneAssets
Total assets¥144.9bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥135.3bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥140.7bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥100.9bnat 2022-03-31StandaloneLiabilities
Total liabilities¥107.9bnat 2021-03-31StandaloneLiabilities
Net assets / equity¥39.2bnat 2022-03-31StandaloneNet assets
Net assets / equity¥37.7bnat 2021-03-31StandaloneNet assets
Net assets / equity¥34.9bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥31.0bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥32.8bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥21.3bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥27.8bnat 2021-03-31StandaloneCash and deposits
EPS (basic)¥77.252021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥116.692020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥155.832019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥77.652018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥138.42017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥252021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥252020-04-01 → 2021-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥502019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥502018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥502017-04-01 → 2018-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,308.05at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,255.8at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,164.12at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,033.3at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,025.74at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio28.0%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio25.9%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio24.1%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio22.9%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio23.3%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE6.0%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE9.6%2020-04-01 → 2021-03-31StandaloneRate of return on equity (5-year summary)
ROE14.2%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE7.6%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
ROE14.2%2017-04-01 → 2018-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued32,048,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued32,048,000at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued16,024,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued16,024,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued16,024,000at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees4,458at 2022-03-31StandaloneNumber of employees
Employees4,034at 2021-03-31StandaloneNumber of employees
Employees3,750at 2020-03-31dStandaloneNumber of employees
Employees3,393at 2019-03-31dStandaloneNumber of employees
Employees3,103at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 70
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2021-04-01 → 2022-03-31¥248m
Reconciling Itemsreconcilingdepreciation2021-04-01 → 2022-03-31¥371m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2022-03-31−¥18.1bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2022-03-31−¥18.1bn
Reconciling Itemsreconcilingsegment assetsat 2022-03-31¥2.0bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2022-03-31−¥6.9bn
Dispensing Pharmacy Businessreportable segmentcapex2021-04-01 → 2022-03-31¥6.4bn
Dispensing Pharmacy Businessreportable segmentdepreciation2021-04-01 → 2022-03-31¥2.6bn
Dispensing Pharmacy Businessreportable segmentemployeesat 2022-03-314195 pure
Dispensing Pharmacy Businessreportable segmentrevenue2021-04-01 → 2022-03-31¥265.6bn
Dispensing Pharmacy Businessreportable segmentrevenue external2021-04-01 → 2022-03-31¥265.6bn
Dispensing Pharmacy Businessreportable segmentsegment assetsat 2022-03-31¥102.9bn
Dispensing Pharmacy Businessreportable segmentsegment profit2021-04-01 → 2022-03-31¥13.0bn
Medical Professional Staffing And Placement Businessreportable segmentcapex2021-04-01 → 2022-03-31¥249m
Medical Professional Staffing And Placement Businessreportable segmentdepreciation2021-04-01 → 2022-03-31¥100m
Medical Professional Staffing And Placement Businessreportable segmentemployeesat 2022-03-31255 pure
Medical Professional Staffing And Placement Businessreportable segmentrevenue2021-04-01 → 2022-03-31¥7.0bn
Medical Professional Staffing And Placement Businessreportable segmentrevenue external2021-04-01 → 2022-03-31¥7.0bn
Medical Professional Staffing And Placement Businessreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥11m
Medical Professional Staffing And Placement Businessreportable segmentsegment assetsat 2022-03-31¥4.2bn
Medical Professional Staffing And Placement Businessreportable segmentsegment profit2021-04-01 → 2022-03-31¥576m
Pharmaceutical Manufacturing And Sales Businessreportable segmentcapex2021-04-01 → 2022-03-31¥1.5bn
Pharmaceutical Manufacturing And Sales Businessreportable segmentdepreciation2021-04-01 → 2022-03-31¥3.5bn
Pharmaceutical Manufacturing And Sales Businessreportable segmentemployeesat 2022-03-31761 pure
Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue2021-04-01 → 2022-03-31¥44.8bn
Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue external2021-04-01 → 2022-03-31¥26.8bn
Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥18.0bn
Pharmaceutical Manufacturing And Sales Businessreportable segmentsegment assetsat 2022-03-31¥69.7bn
Pharmaceutical Manufacturing And Sales Businessreportable segmentsegment profit2021-04-01 → 2022-03-31−¥53m
—segment totalcapex2021-04-01 → 2022-03-31¥8.1bn
—segment totaldepreciation2021-04-01 → 2022-03-31¥6.2bn
—segment totalrevenue2021-04-01 → 2022-03-31¥317.5bn
—segment totalrevenue external2021-04-01 → 2022-03-31¥299.4bn
—segment totalrevenue intersegment2021-04-01 → 2022-03-31¥18.1bn
—segment totalsegment assetsat 2022-03-31¥176.7bn
—segment totalsegment profit2021-04-01 → 2022-03-31¥13.5bn
Reconciling Itemsreconcilingcapex2020-04-01 → 2021-03-31¥402m
Reconciling Itemsreconcilingdepreciation2020-04-01 → 2021-03-31¥327m
Reconciling Itemsreconcilingrevenue2020-04-01 → 2021-03-31−¥19.2bn
Reconciling Itemsreconcilingrevenue intersegment2020-04-01 → 2021-03-31−¥19.2bn
Reconciling Itemsreconcilingsegment assetsat 2021-03-31¥2.4bn
Reconciling Itemsreconcilingsegment profit2020-04-01 → 2021-03-31−¥5.5bn
Dispensing Pharmacy Businessreportable segmentcapex2020-04-01 → 2021-03-31¥6.3bn
Dispensing Pharmacy Businessreportable segmentdepreciation2020-04-01 → 2021-03-31¥2.4bn
Dispensing Pharmacy Businessreportable segmentrevenue2020-04-01 → 2021-03-31¥244.1bn
Dispensing Pharmacy Businessreportable segmentrevenue external2020-04-01 → 2021-03-31¥244.1bn
Dispensing Pharmacy Businessreportable segmentsegment assetsat 2021-03-31¥106.7bn
Dispensing Pharmacy Businessreportable segmentsegment profit2020-04-01 → 2021-03-31¥10.6bn
Medical Professional Staffing And Placement Businessreportable segmentcapex2020-04-01 → 2021-03-31¥98m
Medical Professional Staffing And Placement Businessreportable segmentdepreciation2020-04-01 → 2021-03-31¥91m
Medical Professional Staffing And Placement Businessreportable segmentrevenue2020-04-01 → 2021-03-31¥8.4bn
Medical Professional Staffing And Placement Businessreportable segmentrevenue external2020-04-01 → 2021-03-31¥8.4bn
Medical Professional Staffing And Placement Businessreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥41m
Medical Professional Staffing And Placement Businessreportable segmentsegment assetsat 2021-03-31¥3.6bn
Medical Professional Staffing And Placement Businessreportable segmentsegment profit2020-04-01 → 2021-03-31¥712m
Pharmaceutical Manufacturing And Sales Businessreportable segmentcapex2020-04-01 → 2021-03-31¥2.7bn
Pharmaceutical Manufacturing And Sales Businessreportable segmentdepreciation2020-04-01 → 2021-03-31¥3.6bn
Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue2020-04-01 → 2021-03-31¥45.7bn
Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue external2020-04-01 → 2021-03-31¥26.5bn
Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥19.2bn
Pharmaceutical Manufacturing And Sales Businessreportable segmentsegment assetsat 2021-03-31¥73.6bn
Pharmaceutical Manufacturing And Sales Businessreportable segmentsegment profit2020-04-01 → 2021-03-31¥2.4bn
—segment totalcapex2020-04-01 → 2021-03-31¥9.1bn
—segment totaldepreciation2020-04-01 → 2021-03-31¥6.1bn
—segment totalrevenue2020-04-01 → 2021-03-31¥298.2bn
—segment totalrevenue external2020-04-01 → 2021-03-31¥279.0bn
—segment totalrevenue intersegment2020-04-01 → 2021-03-31¥19.2bn
—segment totalsegment assetsat 2021-03-31¥183.9bn
—segment totalsegment profit2020-04-01 → 2021-03-31¥13.6bn
Dispensing Pharmacy Businessreportable segmentemployeesat 2022-03-314117 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,485
ItemContextValueUnit
Total changes of items during the periodPrior1YearDuration_TreasuryStockMember-0JPY
Total changes of items during the periodPrior1YearDuration_ShareholdersEquityMember2788000000JPY
Net assetsPrior1YearInstant_CapitalStockMember3953000000JPY
Net assetsPrior1YearInstant_CapitalSurplusMember10926000000JPY
Net assetsPrior1YearInstant_RetainedEarningsMember38551000000JPY
Net assetsPrior1YearInstant_TreasuryStockMember-3500000000JPY
Net assetsPrior1YearInstant_ShareholdersEquityMember49931000000JPY
Net assetsPrior2YearInstant_RemeasurementsOfDefinedBenefitPlansMember-70000000JPY
Net assetsPrior2YearInstant_ValuationAndTranslationAdjustmentsMember-70000000JPY
Net assetsPrior2YearInstant47072000000JPY
Dividends from surplusPrior1YearDuration-749000000JPY
Profit loss attributable to owners of parentPrior1YearDuration3538000000JPY
Purchase of treasury stockPrior1YearDuration-0JPY
Net changes of items other than shareholders equityPrior1YearDuration_RemeasurementsOfDefinedBenefitPlansMember6000000JPY
Net changes of items other than shareholders equityPrior1YearDuration_ValuationAndTranslationAdjustmentsMember6000000JPY
Net changes of items other than shareholders equityPrior1YearDuration6000000JPY
Total changes of items during the periodPrior1YearDuration_RemeasurementsOfDefinedBenefitPlansMember6000000JPY
Total changes of items during the periodPrior1YearDuration_ValuationAndTranslationAdjustmentsMember6000000JPY
Total changes of items during the periodPrior1YearDuration2795000000JPY
Net assetsPrior1YearInstant_RemeasurementsOfDefinedBenefitPlansMember-63000000JPY
Net assetsPrior1YearInstant_ValuationAndTranslationAdjustmentsMember-63000000JPY
Net assetsPrior1YearInstant49868000000JPY
Net assetsPrior1YearInstant_CapitalStockMember3953000000JPY
Net assetsPrior1YearInstant_CapitalSurplusMember10926000000JPY
Net assetsPrior1YearInstant_RetainedEarningsMember38551000000JPY
Net assetsPrior1YearInstant_TreasuryStockMember-3500000000JPY
Net assetsPrior1YearInstant_ShareholdersEquityMember49931000000JPY
Dividends from surplusCurrentYearDuration_RetainedEarningsMember-749000000JPY
Dividends from surplusCurrentYearDuration_ShareholdersEquityMember-749000000JPY
Profit loss attributable to owners of parentCurrentYearDuration_RetainedEarningsMember3705000000JPY
Profit loss attributable to owners of parentCurrentYearDuration_ShareholdersEquityMember3705000000JPY
Purchase of treasury stockCurrentYearDuration_TreasuryStockMember-0JPY
Purchase of treasury stockCurrentYearDuration_ShareholdersEquityMember-0JPY
Total changes of items during the periodCurrentYearDuration_CapitalStockMember－JPY
Total changes of items during the periodCurrentYearDuration_CapitalSurplusMember－JPY
Total changes of items during the periodCurrentYearDuration_RetainedEarningsMember2955000000JPY
Total changes of items during the periodCurrentYearDuration_TreasuryStockMember-0JPY
Total changes of items during the periodCurrentYearDuration_ShareholdersEquityMember2955000000JPY
Net assetsCurrentYearInstant_CapitalStockMember3953000000JPY
Net assetsCurrentYearInstant_CapitalSurplusMember10926000000JPY
Net assetsCurrentYearInstant_RetainedEarningsMember41507000000JPY
Net assetsCurrentYearInstant_TreasuryStockMember-3500000000JPY
Net assetsCurrentYearInstant_ShareholdersEquityMember52887000000JPY
Net assetsPrior1YearInstant_RemeasurementsOfDefinedBenefitPlansMember-63000000JPY
Net assetsPrior1YearInstant_ValuationAndTranslationAdjustmentsMember-63000000JPY
Net assetsPrior1YearInstant49868000000JPY
Dividends from surplusCurrentYearDuration-749000000JPY
Profit loss attributable to owners of parentCurrentYearDuration3705000000JPY
Purchase of treasury stockCurrentYearDuration-0JPY
Net changes of items other than shareholders equityCurrentYearDuration_RemeasurementsOfDefinedBenefitPlansMember53000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2021-03-31pass rounding
balance sheet identitynon_consolidated 2022-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2020-03-31pass
statement vs summary · net assetsconsolidated 2021-03-31pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2020-04-01/2021-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass